Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies.
Larsson SC, Wolk A. · 2007
Read Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. by Larsson SC, Wolk A. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2360408.txt.
Introduction
Larsson and Wolk combined cohort studies on body weight and liver cancer in 2007. A cohort study follows groups of people over time and records who falls ill. Liver cancer is often fatal within months, and its rates had been climbing in rich countries for reasons not fully explained.
The search covered medical databases from 1966 to mid-2007 and found 11 usable studies. Compared with people of normal weight, overweight people had a relative risk of 1.17 for liver cancer, while obese people had a relative risk of 1.89, close to double. The overweight analysis covered 5,037 cases and the obesity analysis 6,042 cases. The authors concluded that excess weight raises liver cancer risk in a clear, graded way.
Catalog record
| CREATOR | Larsson SC, Wolk A. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies By S C Larsson, A Wolk Published in: British Journal of Cancer DOI: 10.1038/sj.bjc.6603932 ABSTRACT Cohort studies of excess body weight and risk of liver cancer were identified for a meta-analysis by searching MEDLINE and EMBASE databases from 1966 to June 2007 and the reference lists of retrieved articles. Results from individual studies were combined using a random-effects model. We identified 11 cohort studies, of which seven on overweight (with a total of 5037 cases) and 10 on obesity (with 6042 cases) were suitable for meta-analysis. Compared with persons of normal weight, the summary relative risks of liver cancer were 1.17 (95% confidence interval (CI): 1.02–1.34) for those who were overweight and 1.89 (95% CI: 1.51–2.36) for those who were obese. This meta-analysis finds that excess body weight is associated with an increased risk of liver cancer. Although relatively rare in the United States and other developed countries, liver cancer is the third most common cause of death from cancer worldwide (Parkin et al, 2005). It is rarely detected early and is often fatal within a few months of diagnosis. The 5-year survival rate is only about 6–11% (Coleman et al, 2003; Ries et al, 2006). The age-adjusted incidence and mortality rates of liver cancer have been increasing rapidly in the United States since the mid-1980s (Ries et al, 2006). While approximately half of this increase can be attributable to hepatitis C virus infection, a minimal or no increase has been related to hepatitis B virus and alcoholic liver disease (El-Serag and Mason, 2000; Hassan et al, 2002). Given that about half of the increase in liver cancer incidence is not related to hepatitis, the major risk factor in a significant proportion of the cases has yet to be identified. Coinciding with the rising incidence of liver cancer, the prevalence of obesity has been increasing markedly over the past two decades worldwide (Larsson and Wolk, 2006). Obesity has been recognised as a risk factor for several malignancies, including cancer of the breast (in premenopausal women), endometrium, kidney (renal cell), colon, pancreas, gallbladder, and esophagus (adenocarcinoma) (IARC, 2002; Larsson et al, 2007; Larsson and Wolk, 2007). Accumulating epidemiologic evidence also indicates that excess body weight may be a risk factor for liver cancer, but the evidence has not been quantitatively summarised. We have therefore quantitatively assessed the associations of overweight and obesity with liver cancer risk in a meta-analysis of cohort studies. MATERIALS AND METHODS Study selection A literature search was conducted in the MEDLINE and EMBASE databases for pertinent studies published in any language from 1966 to June 2007. We used the keywords ‘body mass index’, ‘BMI’, or ‘obesity’ in combination with ‘hepatocellular carcinoma’, ‘liver cancer’, or ‘liver neoplasm’. Moreover, we manually reviewed the reference lists of retrieved articles to search for more studies. Studies were included in the meta-analysis if they fulfilled the following criteria: (1) cohort study in which liver cancer incidence or mortality was an outcome; (2) the exposure of interest was overweight and/or obesity defined by body mass index (BMI) (the weight in kilograms divided by the square of height in meters); and (3) relative risk estimates (rate ratio or standardized incidence ratio) with corresponding 95% confidence intervals (CIs) were reported. Data extraction For each study, the following information was extracted: first author's last name; publication year; country in which the study was performed; sample size; method of assessing weight and height; type of outcome (incidence or mortality); variables adjusted for in the analysis; and the relative risks with 95% CIs for overweight and obesity vs normal weight. From each study, we extracted the most fully adjusted relative risks. Statistical analysis The relative risks and corresponding standard errors (derived from the CIs) from individual studies were logarithmically transformed to stabilize variances and normalize the distributions. We calculated summary relative risks for overweight (defined as BMI 25–30 kg m−2) and obesity (BMI ⩾30 kg m−2) vs normal weight (BMI 18.5–24.9 kg m−2). For two studies (Calle et al, 2003; Kuriyama et al, 2005) that reported relative risks for two categories of BMI that fell into the category representing overweight or obesity, we pooled the relative risks and used the pooled estimate in the meta-analysis. Study-specific relative risks were combined using the DerSimonian and Laird random-effects model (DerSimonian and Laird, 1986). Thus, each summary relative risk was a weighted average of the study-specific relative risk, where the weight for each study is the inverse of the sum of the within-study variance for that study, and the between-study variance. Statistical heterogeneity among studies was evaluated with the Q and I2 statistics (Higgins and Thompson, 2002). For the Q statistic, statistical significance was set at P<0.1. We used funnel plots (i.e. plots of study results against precision) to assess publication bias, and tested the symmetry of the funnel plot using Egger's test (Egger et al, 1997). Results are presented graphically, whereby squares represent study-specific relative risks and diamonds represent summary relative risks. The area of each square is proportional to the inverse of the variance of the logarithm of the relative risk; 95% CIs for individual studies are represented by horizontal lines and for the summary estimates by the width of the diamonds. Statistical analyses were performed with Stata, version 9.0 (StataCorp, College Station, TX, USA). Population attributable risk (PAR) for liver cancer was estimated for individuals with excess body weight (BMI⩾25 kg m−2) compared to those of normal weight (BMI<25 kg m−2). The PAR describes the theoretic proportion of cases that would be prevented if all individuals were moved into the exposure level associated with the lowest risk for that factor. The PAR (PAR%) was calculated as: PAR%=(p × [RR–1]/[p × (RR–1)+1]) × 100%, where p represents the prevalence in the population and RR the relative risk. Prevalence data were obtained from the National Health and Nutrition Examination Survey that assessed the prevalence of overweight and obesity in a representative sample of the US population (Ogden et al, 2006). In that survey, 39.7% of the men were overweight and 31.1% were obese. Among women, 28.6% were overweight and 33.2% were obese. PARs were calculated for the overweight and obese categories using the obtained summary relative risks, and then summarized across the two categories for men and women separately. RESULTS We identified 11 eligible cohort studies (Møller et al, 1994; Wolk et al, 2001; Nair et al, 2002; Calle et al, 2003; Samanic et al, 2004, 2006; Batty et al, 2005; Kuriyama et al, 2005; Oh et al, 2005; Rapp et al, 2005; N'Kontchou et al, 2006), of which 7 on overweight (with a total of 5037 cases) (Calle et al, 2003; Batty et al, 2005; Kuriyama et al, 2005; Oh et al, 2005; Rapp et al, 2005; N'Kontchou et al, 2006; Samanic et al, 2006) and 10 on obesity (with a total of 6042 cases) (Møller et al, 1994; Wolk et al, 2001; Nair et al, 2002; Calle et al, 2003; Samanic et al, 2004, 2006; Batty et al, 2005; Oh et al, 2005; Rapp et al, 2005; N'Kontchou et al, 2006) were suitable for meta-analysis. Characteristics of the studies are shown in Table 1. Seven studies